A nurse is teaching a client who has active pulmonary tuberculosis about management of medication for the disease. Which of the following statements is appropriate for the nurse to make?

A. Naloxone IV:
This choice is incorrect. Naloxone is an opioid receptor antagonist used to reverse the effects of opioid overdose. It works by displacing opioids from the receptors and rapidly reversing their effects. However, in this scenario, the client is experiencing pain 1 hour after receiving morphine, indicating that the morphine's analgesic effects have likely worn off. Naloxone is not used to manage pain, but rather to reverse opioid overdose.

B. Fentanyl transmucosal:
This choice is incorrect. Fentanyl transmucosal formulations are used for breakthrough pain in opioid-tolerant patients with chronic pain conditions. It is not typically the first choice for immediate pain relief after intravenous morphine administration. Additionally, it's worth noting that fentanyl transmucosal products, like fentanyl lollipops, are usually reserved for chronic pain management and may not be suitable for immediate post-administration pain relief.

C. Morphine tablet:
This is the correct choice. If the client is experiencing pain 1 hour after receiving morphine intravenously, it's reasonable to administer an oral or sublingual form of morphine for continued pain relief. Morphine tablets are commonly used for pain management and can provide sustained relief over a longer duration. This choice aligns with the patient's initial prescription for pain control.

D. Lidocaine patch:
This choice is incorrect. Lidocaine patches are used to manage localized neuropathic pain, such as postherpetic neuralgia. They work by numbing the skin and underlying tissues in the area where they are applied. While lidocaine patches can be effective for certain types of pain, they are not typically used to address the acute pain associated with cancer and immediate post-administration pain relief.

A. Estrogen-progestin combination:
Correct Answer: This medication interacts with carbamazepine.
Explanation: Carbamazepine is known to induce certain liver enzymes, including cytochrome P450 enzymes. These enzymes play a role in the metabolism of various medications, including estrogen-containing oral contraceptives (estrogen-progestin combinations). Carbamazepine can increase the metabolism of estrogen-progestin combinations, potentially reducing their effectiveness and increasing the risk of contraceptive failure. Therefore, this interaction can lead to decreased contraceptive efficacy and the potential for unintended pregnancy.
B. Nicotine transdermal system:
Incorrect Explanation: This medication does not interact with carbamazepine.
Explanation: Nicotine replacement therapies, such as nicotine transdermal systems, are not known to have significant interactions with carbamazepine. These therapies are primarily used to aid in smoking cessation and do not share metabolic pathways with carbamazepine.
C. Diphenhydramine:
Incorrect Explanation: This medication does not interact with carbamazepine.
Explanation: Diphenhydramine is an antihistamine used for allergies and as a sleep aid. It does not have a well-established interaction with carbamazepine. However, it's important to note that carbamazepine can have central nervous system (CNS) effects, so caution should be exercised when combining it with other medications that also have CNS effects.
D. Beclomethasone:
Incorrect Explanation: This medication does not interact with carbamazepine.
Explanation: Beclomethasone is a corticosteroid used to manage inflammation associated with conditions like asthma and allergic rhinitis. It is not known to interact with carbamazepine. These two medications have different mechanisms of action and do not share significant metabolic pathways.